Aspire Biopharma (ASBP) announced that its Board of Directors has elected Michael Howe, as the Company’s new CEO. Kraig Higginson, who has stepped down as CEO and Chairman of the Board, will remain with the Company and serve as Executive Chairman of the Board. Since 2022, Howe has served as a Co-founder and CEO of The Good Clinic.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP:
- Aspire Biopharma provides development update on BUZZ BOMB supplement
- Aspire announces first patient dosed in Phase 1 trial of aspirin formulation
- Aspire Biopharma files to sell 8.33M shares of common stock for holders
- Aspire announces IRB approval for in-human trial of aspirin formulation
- Aspire commences initial production of pre-workout performance supplement